NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $254,166 | +22.6% | 2,495 | +21.4% | 0.02% | 0.0% |
| Q2 2023 | $207,379 | -25.7% | 2,055 | -33.2% | 0.02% | -35.1% |
| Q4 2022 | $278,999 | -5.7% | 3,075 | -21.1% | 0.04% | -17.8% |
| Q3 2022 | $296,000 | -14.2% | 3,895 | -4.7% | 0.04% | -11.8% |
| Q2 2022 | $345,000 | +3.9% | 4,086 | +7.9% | 0.05% | +18.6% |
| Q1 2022 | $332,000 | +15.3% | 3,788 | +15.0% | 0.04% | +13.2% |
| Q4 2021 | $288,000 | +77.8% | 3,295 | +65.5% | 0.04% | +65.2% |
| Q3 2021 | $162,000 | -19.8% | 1,991 | -10.4% | 0.02% | -8.0% |
| Q2 2021 | $202,000 | +197.1% | 2,222 | +176.0% | 0.02% | +127.3% |
| Q1 2021 | $68,000 | +4.6% | 805 | +16.7% | 0.01% | -21.4% |
| Q4 2020 | $65,000 | -99.9% | 690 | +20.6% | 0.01% | -53.3% |
| Q1 2020 | $47,160,000 | -7.5% | 572 | +9.6% | 0.03% | -3.2% |
| Q4 2019 | $51,008,000 | – | 522 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |